Cargando…
Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial
BACKGROUND: Trichuris suis ova is a probiotic treatment based on the hygiene hypothesis. It has been demonstrated as safe and effective in autoimmune inflammatory bowel diseases and clinical trials indicate that helminth infections also have an immunomodulatory effect in multiple sclerosis. We hypot...
Autores principales: | Rosche, Berit, Wernecke, Klaus-Dieter, Ohlraun, Stephanie, Dörr, Jan-Markus, Paul, Friedemann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680966/ https://www.ncbi.nlm.nih.gov/pubmed/23782752 http://dx.doi.org/10.1186/1745-6215-14-112 |
Ejemplares similares
-
The Worm-Specific Immune Response in Multiple Sclerosis Patients Receiving Controlled Trichuris suis Ova Immunotherapy
por: Yordanova, Ivet A., et al.
Publicado: (2021) -
Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy
por: Rosche, Berit, et al.
Publicado: (2013) -
Trichuris suis ova therapy in inflammatory bowel disease: A meta-analysis
por: Huang, Xing, et al.
Publicado: (2018) -
Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis
por: Paul, Friedemann, et al.
Publicado: (2008) -
Influence of NOD2 Variants on Trichuris suis ova Treatment Outcome in Crohn’s Disease
por: Jaeger, Simon U., et al.
Publicado: (2018)